BPA- Drug Screening Services

The District of Columbia is seeking a Blanket Purchase Agreement (BPA) for Drug Screening Services, a procurement opportunity targeting comprehensive medical testing and screening capabilities. This contract appears focused on providing drug testing services for various district agencies, likely including pre-employment screenings, random testing, and post-incident evaluations. The solicitation, identified by contract ID 66c85bb1829eb5d8690735f0, was posted on June 19, 2015, with a tight response deadline of June 24, 2015, indicating an expedited procurement process. While specific technical requirements are not detailed in the provided information, potential vendors would likely need extensive experience in clinical drug testing, laboratory capabilities, chain of custody procedures, and compliance with federal and local testing standards. The abbreviated timeline suggests an urgent need for these screening services, with potential vendors expected to demonstrate rapid response capabilities and comprehensive testing methodologies.

Given the limited information provided, potential set-aside designations or specific vendor restrictions cannot be definitively confirmed. The contract appears to be a standard procurement opportunity for the District of Columbia, potentially open to various qualified medical testing and screening providers. No incumbent vendors or specific budget ranges are explicitly mentioned in the available data. Interested vendors would need to carefully review the full solicitation documentation to understand precise qualifications, technical specifications, and potential contract value. Prospective bidders should be prepared to demonstrate extensive experience in drug screening services, laboratory certifications, and the ability to meet the District of Columbia's specific testing requirements within a compressed procurement timeline.